Van Eck Associates Corp
- SEC CIK
- 0000869178
- Latest filing
- Aug 14, 2026
ARWR holding history
Arrowhead Pharmaceuticals, Inc. in every 13F filed by Van Eck Associates Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings
- Shares (Q2 2026)
- 111,500
- Value
- $9.09M
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 111,500 | $9.09M | <0.1% | +92,610+490.3% | Added | Holders |
| Q1 2026 | 18,890 | $1.18M | <0.1% | +12,453+193.5% | Added | Holders |
| Q4 2025 | 6,437 | $427.0K | <0.1% | +3,261+102.7% | Added | Holders |
| Q3 2025 | 3,176 | $110.0K | <0.1% | +62+2.0% | Added | Holders |
| Q2 2025 | 3,114 | $49.0K | <0.1% | −68−2.1% | Reduced | Holders |
| Q1 2025 | 3,182 | $41.0K | <0.1% | +204+6.9% | Added | Holders |
| Q4 2024 | 2,978 | $56.0K | <0.1% | +1,250+72.3% | Added | Holders |
| Q3 2024 | 1,728 | $34.0K | <0.1% | −1,250−42.0% | Reduced | Holders |
| Q2 2024 | 2,978 | $77.0K | <0.1% | −252−7.8% | Reduced | Holders |
| Q1 2024 | 3,230 | $92.0K | <0.1% | +835+34.9% | Added | Holders |
| Q4 2023 | 2,395 | $73.0K | <0.1% | +447+22.9% | Added | Holders |
| Q3 2023 | 1,948 | $52.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,948 | $69.0K | <0.1% | −184−8.6% | Reduced | Holders |
| Q1 2023 | 2,132 | $54.0K | <0.1% | +46+2.2% | Added | Holders |
| Q4 2022 | 2,086 | $85.0K | <0.1% | +511+32.4% | Added | Holders |
| Q3 2022 | 1,575 | $52.0K | <0.1% | +1,575 | New | Holders |